Go Pro
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

Pro-Dex logo
$68.82 -1.21 (-1.72%)
As of 01:01 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Pro-Dex Stock (NASDAQ:PDEX)

Advanced

Key Stats

Today's Range
$68.60
▼
$70.44
50-Day Range
$53.43
▼
$73.41
52-Week Range
$23.47
▼
$77.00
Volume
13,038 shs
Average Volume
51,866 shs
Market Capitalization
$220.21 million
P/E Ratio
16.66
Dividend Yield
N/A
Price Target
$74.00
Consensus Rating
Buy

Company Overview

Pro-Dex, Inc. is a medical device manufacturer that designs, develops and produces powered surgical instruments and related equipment. The company primarily serves original equipment manufacturers (OEMs), which incorporate Pro-Dex products into surgical systems sold under their own brands.

Its product portfolio includes battery-powered and electric handpieces, controllers, drivers, saws, microdebriders and other precision instruments used in medical and dental procedures. Pro-Dex also provides related components and accessories, including batteries, chargers and instrument controls, as well as engineering, manufacturing and product-development support for its customers.

Based in Irvine, California, Pro-Dex serves customers in the United States and international markets. Its products are used in areas such as orthopedic, spinal, dental and other specialized surgical applications. The company’s business is focused on combining medical-device engineering and contract manufacturing capabilities to produce instruments designed for specific clinical and OEM requirements.

AI Generated. May Contain Errors.

Pro-Dex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

PDEX MarketRank™: 

Pro-Dex scored higher than 59% of companies evaluated by MarketBeat, and ranked 380th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside/Downside

    The consensus price target for Pro-Dex is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Pro-Dex has only been the subject of 3 research reports in the past 90 days.

  • Read more about Pro-Dex's stock forecast and price target.
  • Earnings Growth

    Earnings for Pro-Dex are expected to grow by 8.74% in the coming year, from $3.09 to $3.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pro-Dex is 16.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.77.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pro-Dex is 16.80, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.16.

  • Price to Book Value per Share Ratio

    Pro-Dex has a P/B Ratio of 4.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pro-Dex's valuation and earnings.
  • Percentage of Shares Shorted

    12.11% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 2.29, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 17.40%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pro-Dex does not currently pay a dividend.

  • Dividend Growth

    Pro-Dex does not have a long track record of dividend growth.

  • News Sentiment

    Pro-Dex has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pro-Dex this week, compared to 1 article on an average week.
  • Search Interest

    5 people have searched for PDEX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,351,657.00 in company stock.

  • Percentage Held by Insiders

    45.90% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    15.28% of the stock of Pro-Dex is held by institutions.

  • Read more about Pro-Dex's insider trading history.
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PDEX Stock News Headlines

Contrasting Precision Optics (NASDAQ:POCI) & Pro-Dex (NASDAQ:PDEX)
Ascendiant Capital Markets Forecasts Pro-Dex Q4 Earnings
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel
Pro-Dex (NASDAQ:PDEX) CEO Sells 765 Shares of Stock
Pro-Dex (NASDAQ:PDEX) CFO Sells 2,300 Shares
See More Headlines

PDEX Stock Analysis - Frequently Asked Questions

Pro-Dex's stock was trading at $38.48 on January 1st, 2026. Since then, PDEX stock has increased by 80.5% and is now trading at $69.4680.

Pro-Dex, Inc. (NASDAQ:PDEX) posted its earnings results on Thursday, September, 3rd. The medical instruments supplier reported $0.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.20. The medical instruments supplier had revenue of $20.41 million for the quarter, compared to analysts' expectations of $19.20 million. Pro-Dex had a trailing twelve-month return on equity of 25.13% and a net margin of 17.62%.

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL).

Company Calendar

Last Earnings
9/03/2026
Today
9/30/2026
Next Earnings (Estimated)
10/29/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:PDEX
CIK
788920
Employees
206
Year Founded
1975

Price Target and Rating

High Price Target
$74.00
Low Price Target
$74.00
Potential Upside/Downside
+7.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.13
Trailing P/E Ratio
16.70
Forward P/E Ratio
22.32
P/E Growth
N/A
Net Income
$13.66 million
Net Margins
17.62%
Pretax Margin
23.23%
Return on Equity
25.13%
Return on Assets
16.02%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
4.10
Quick Ratio
2.45

Sales & Book Value

Annual Sales
$77.55 million
Price / Sales
2.85
Cash Flow
$3.76 per share
Price / Cash Flow
18.35
Book Value
$14.92 per share
Price / Book
4.62

Miscellaneous

Outstanding Shares
3,200,000
Free Float
1,733,000
Market Cap
$220.69 million
Optionable
Not Optionable
Beta
0.06

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:PDEX) was last updated on 9/30/2026 by MarketBeat.com Staff.
From Our Partners